相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atrial fibrillation risk factors in patients with ischemic stroke
Pawel Wankowicz et al.
ARCHIVES OF MEDICAL SCIENCE (2021)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
Thirty-Second Gold Standard Definition of Atrial Fibrillation and Its Relationship With Subsequent Arrhythmia Patterns Analysis of a Large Prospective Device Database
Jonathan S. Steinberg et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2018)
Source of Chronic Inflammation in Aging
Fumihiro Sanada et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
The role of obesity in atrial fibrillation
Chrishan Joseph Nalliah et al.
EUROPEAN HEART JOURNAL (2016)
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)
Natalia S. Rost et al.
STROKE (2016)
Epidemiology of atrial fibrillation: European perspective
Massimo Zoni-Berisso et al.
CLINICAL EPIDEMIOLOGY (2014)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Atrial fibrillation prevalence revisited
L. Friberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors The Atherosclerosis Risk in Communities (ARIC) Study
Rachel R. Huxley et al.
CIRCULATION (2011)
The cost of illness of atrial fibrillation: a systematic review of the recent literature
S. E. Wolowacz et al.
EUROPACE (2011)
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial
R. Bulbulia et al.
LANCET (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial (vol 9, pg 1157, 2010)
H. C. Diener et al.
LANCET NEUROLOGY (2011)
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial
Alison Halliday et al.
LANCET (2010)
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
Hans Chnstoph Diener et al.
LANCET NEUROLOGY (2010)
Smoking and stroke: the more you smoke the more you stroke
Reena S. Shah et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
David Conen et al.
CIRCULATION (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
Jeffrey L. Anderson et al.
CIRCULATION (2007)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
2007 guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2007)
Immunosenescence: emerging challenges for an ageing population
Danielle Aw et al.
IMMUNOLOGY (2007)
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
M Wadelius et al.
PHARMACOGENOMICS JOURNAL (2005)
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
G D'Andrea et al.
BLOOD (2005)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women - The JPHC Study Cohort I
T Mannami et al.
STROKE (2004)
Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?
A Evans et al.
STROKE (2001)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Cardiogenic embolism as the main cause of ischemic stroke in a city hospital:: An interdisciplinary study
EI Becker et al.
VASA-JOURNAL OF VASCULAR DISEASES (2001)
The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis
D Inzitari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The left atrial appendage: our most lethal human attachment! Surgical implications
WD Johnson et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2000)
分享论文
